435
Views
11
CrossRef citations to date
0
Altmetric
Letters

Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes

ORCID Icon, , , &
Pages 2386-2390 | Received 05 May 2021, Accepted 25 May 2021, Published online: 14 Jun 2021
 

Disclosure statement

Dr. Ortega-Loayza has participated in Advisory Boards for Janssen and Bristol Mayer Squibb. Authors declare that the contents of this article are their own original unpublished findings.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.